Hemodynamic responses to combined therapy with captopril and hydralazine in patients with severe heart failure (Q42247394)

19 October 2017

title

Hemodynamic responses to combined therapy with captopril and hydralazine in patients with severe heart failure (English)

1 reference

Cardiology and cardiovascular medicine

19 October 2017

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(83)80172-7

4 October 2023

author name string

B. M. Massie

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6345633

4 October 2023

M. Packer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6345633

4 October 2023

J. T. Hanlon

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6345633

4 October 2023

D. T. Combs

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6345633

4 October 2023

language of work or name

English

0 references

publication date

1 August 1983

1 reference

full work available at URL

19 October 2017

https://api.elsevier.com/content/article/PII:S0735109783801727?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(83)80172-7

https://api.elsevier.com/content/article/PII:S0735109783801727?httpAccept=text/plain

4 October 2023

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(83)80172-7

Journal of the American College of Cardiology

4 October 2023

published in

1 reference

19 October 2017

volume

2

1 reference

19 October 2017

issue

2

1 reference

19 October 2017

page(s)

338-344

1 reference

Controlled trial of captopril in chronic heart failure: a rest and exercise hemodynamic study

19 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980172-7

7 January 2021

Treatment of Chronic Congestive Heart Failure with Captopril, an Oral Inhibitor of Angiotensin-Converting Enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980172-7

7 January 2021

Renin, aldosterone and cardiac decompensation: Studies with an oral converting enzyme inhibitor in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980172-7

7 January 2021

Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980172-7

7 January 2021

Acute and long-term response to an oral converting-enzyme inhibitor, captopril, in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980172-7

7 January 2021

Sustained Effectiveness of Converting-Enzyme Inhibition in Patients with Severe Congestive Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980172-7

7 January 2021

Angiotensin inhibition in severe heart failure: acute central and limb hemodynamic effects of captopril with observations on sustained oral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980172-7

7 January 2021

Haemodynamic, hormonal, and electrolyte responses to captopril in resistant heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980172-7

7 January 2021

Efficacy of oral angiotensin-converting enzyme inhibition with captopril therapy in severe chronic normotensive congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980172-7

7 January 2021

Hemodynamic and radionuclide effects of acute captopril therapy for heart failure: changes in left and right ventricular volumes and function at rest and during exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980172-7

7 January 2021

Oral hydralazine in chronic heart failure: sustained beneficial hemodynamic effects

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980172-7

7 January 2021

Hemodynamic improvement after oral hydralazine in left ventricular failure: a comparison with nitroprusside infusion in 16 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980172-7

7 January 2021

Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980172-7

7 January 2021

Effect of hydralazine on renal failure in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980172-7

7 January 2021

Hemodynamic characterization of tolerance to long-term hydralazine therapy in severe chronic heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980172-7

7 January 2021

Determinants of drug response in severe chronic heart failure. 1. Activation of vasoconstrictor forces during vasodilator therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980172-7

7 January 2021

Mechanisms and implications of vasodilator tolerance in the treatment of congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980172-7

7 January 2021

A comparison of the effects of vasodilator stimuli on peripheral resistance vessels in normal subjects and in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980172-7

7 January 2021

Importance of left ventricular chamber size in determining the response to hydralazine in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980172-7

7 January 2021

Dose requirements of hydralazine in patients with severe chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980172-7

7 January 2021

Postural hypotension and tachycardia during hydralazine--isosorbide dinitrate therapy for chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980172-7

7 January 2021

Long-term vasodilator therapy for heart failure: clinical response and its relationship to hemodynamic measurements.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980172-7

7 January 2021

Physiologic and pharmacologic determinants of vasodilator response: a conceptual framework for rational drug therapy for chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2883%2980172-7

7 January 2021

Identifiers

1 reference

19 October 2017

1 reference